Effect of short hairpin RNA-mediated adiponectin/Acrp30 down-regulation on insulin signaling and glucose uptake in the 3T3-L1 adipocytes

Journal of Endocrinological Investigation

Volumn 33, Issue 2, 2010, Pages 96-102

  Li, K ^a   Li, L ^a   Yang, G Y ^a   Liu, H ^b   Li, S B ^a   Boden, G ^c  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

3T3 L1 adipocytes; Adiponectin; Glucose turnover; Insulin signaling; RNA interference

Indexed keywords

ADIPONECTIN; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; HORMONE SENSITIVE LIPASE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; SHORT HAIRPIN RNA; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL LEVEL; CELL STRAIN 3T3; CONTROLLED STUDY; DOWN REGULATION; GENE DELETION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC TRANSFECTION; GLUCOSE TRANSPORT; INSULIN LIKE ACTIVITY; LIPID COMPOSITION; MOUSE; NONHUMAN; PROTEIN CONTENT; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

3T3-L1 CELLS; ADIPOCYTES; ADIPONECTIN; ANIMALS; CARBOXYLIC ESTER HYDROLASES; DOWN-REGULATION; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; GLUCOSE TRANSPORTER TYPE 4; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; MICE; PPAR ALPHA; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STEROL ESTERASE; TRANSFECTION; TRIGLYCERIDES;

EID: 77951870446     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/6481     Document Type: Article

References (26)

1. Rajala MW, Scherer PE. Minireview: The adipocyte - at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 2003, 144: 3765-3773
2. Trayhurn P. Endocrine and signaling role of adipose tissue: new perspectives on fat. Acta Physiol Scand 2005, 184: 285-293 (Pubitemid 41039735)
3. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999, 257: 79-83.
4. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The adipocyte secreted protein Acrp30 enhances hepatic insulin action. Nat Med 2001, 7: 947-953 (Pubitemid 32756433)
5. Wu X, Motoshima H, Mahadev K, Stalker TJ, Scalia R, Goldstein BJ. Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes. Diabetes 2003, 52: 1355-1363 (Pubitemid 36666188)
6. Tomas E, Tsao TS, Saha AK, et al. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMPactivated protein kinase activation. Proc Natl Acad Sci U S A 2002, 99: 16309-16313
7. Yamauchi T, Kamon J, Minokoshi Y, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP activated protein kinase. Nat Med 2002, 8: 1288-1295
8. Hotta K, Funahashi T, Arita Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Bio 2000, 20: 1595-1599
9. Kubota N, Terauchi Y, Yamauchi T, et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 2002, 277: 25863-25866
10. Maeda N, Shimomura I, Kishida K, et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 2002, 8: 731-737
11. Schwarz PE, Towers GW, Fischer S, et al. Hypoadiponectinemia is associated with progression toward type 2 diabetes and genetic variation in the ADIPOQ gene promoter. Diabetes Care 2006, 29: 1645-1650
12. Zacharova J, Chiasson JL, Laakso M; STOP-NIDDM Study Group. The common polymorphisms (single nucleotide polymorphism [SNP] +45 and SNP +276) of the adiponectin gene predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial. Diabetes 2005, 54: 893-899
13. Schmitz-Peiffer C, Whitehead JP. IRS-1 regulation in health and disease. IUBMB Life 2003, 55: 367-374
14. Ma K, Cabrera A, Saha PK, et al. Increased beta-oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin. J Biol Chem 2002, 277: 34658-34661
15. Blagoev B, Kratchmarova I, Nielsen MM, et al. Inhibition of adipocyte differentiation by resistin-like molecule alpha. Biochemical characterization of its oligomeric nature. J Biol Chem 2002, 277: 42011-42016
16. Thomson MJ, Williams MG, Frost SC. Development of insulin resistance in 3T3-L1 adipocytes. J Biol Chem 1997, 272: 7759-7764
17. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001, 411: 494-498
18. Hannon GJ, Rossi JJ. Unlocking the potential of the human genome with RNA interference. Nature 2004, 431: 371-378
19. Lienhard GE, Slot JW, James DE, Mueckler MM. How cells absorb glucose? Sci Am 1992, 266: 86-91.
20. Kraemer FB, Shen WJ. Hormone sensitive lipase: control of intracellular tri-(di-)acylglycerol and cholesteryl ester hydrolysis. J Lipid Res 2002, 43: 1585-1594
21. Zimmermann R, Strauss JG, Haemmerle G, et al. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 2004, 306: 1383-1386 (Pubitemid 39532517)
22. Tsuchida A, Yamauchi T, Takekawa S, et al. Peroxisome proliferator-activated receptor (PPAR)alpha activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARalpha, PPARgamma, and their combination. Diabetes 2005, 54: 3358-3370 (Pubitemid 43334324)
23. Iwaki M, Matsuda M, Maeda N, et al. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 2003, 52: 1655-1663 (Pubitemid 36792453)
24. Yamauchi T, Kamon J, Ito Y, et al. Cloning of adiponectin receptors that mediate antidiabetics metabolism effects. Nature 2003, 423: 762-769
25. Wang Y, Lam KS, Chan L, et al. Post-translational modifications of the four conserved lysine residues within the collagenous domain of adiponectin are required for the formation of its high molecular weight oligomeric complex. J Biol Chem 2006, 281: 16391-16400
26. Hara K, Horikoshi M, Yamauchi T, et al. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care 2006, 29: 1357-1362